Focus: Genomics is a UK-based biotechnology company specializing in human genetics platforms focused on rare diseases and genomic diagnostics. The company operates as a platform for genomic sequencing, molecular diagnostics, and biomarker discovery across oncology, rare genetic disorders, and transplant monitoring.
Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago
Stable — net +1 jobs in 30d
8 added, 7 removed. Backfill posture.
Early-stage genomics platform with interesting science but significant data gaps and hiring stagnation; viable for specialists seeking ground-floor opportunity in precision medicine, but carries pre-revenue biotech risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Recently launched local anesthetic with extended exclusivity; peripheral to core genomics strategy and likely licensed asset.
Help build intelligence for Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Precision Medicine Market to Reach US$ 292.12 Billion by 2032 | Genomics, Targeted Therapies and Personalized Healthcare Demand Expands - facilitiesmanagement-now.com
Precision Medicine Market to Reach US$ 292.12 Billion by 2032 | Genomics, Targeted Therapies and Personalized Healthcare Demand Expands facilitiesmanagement-now.com
Why is AI in Genomics the Next Big Thing in Drug Discovery - Kavout
Why is AI in Genomics the Next Big Thing in Drug Discovery Kavout
8-K Filing: RAMBUS INC (RMBS) (CIK 0000917273) — 8-K
8-K
8-K Filing: Profusa, Inc. (PFSA, NVACW) (CIK 0001859807) — CURRENT REPORT
CURRENT REPORT
Fortis Healthcare launches preventive genomics clinic in Bengaluru to boost precision medicine - ET HealthWorld
Fortis Healthcare launches preventive genomics clinic in Bengaluru to boost precision medicine ET HealthWorld
M Tech Bioinformatics: Career Scope in Genomics, Pharma & AI Healthcare - Shoolini University
M Tech Bioinformatics: Career Scope in Genomics, Pharma & AI Healthcare Shoolini University
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo